These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
298 related items for PubMed ID: 15232117
1. Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale. Homma S, DiTullio MR, Sacco RL, Sciacca RR, Mohr JP, PICSS Investigators. Stroke; 2004 Sep; 35(9):2145-9. PubMed ID: 15232117 [Abstract] [Full Text] [Related]
4. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, Mattle HP, Meier B. J Am Coll Cardiol; 2004 Aug 18; 44(4):750-8. PubMed ID: 15312853 [Abstract] [Full Text] [Related]
6. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial. Elmariah S, Furlan AJ, Reisman M, Burke D, Vardi M, Wimmer NJ, Ling S, Chen X, Kent DM, Massaro J, Mauri L, CLOSURE I Investigators. JACC Cardiovasc Interv; 2014 Aug 18; 7(8):913-20. PubMed ID: 25147037 [Abstract] [Full Text] [Related]
9. Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale. Schuchlenz HW, Weihs W, Berghold A, Lechner A, Schmidt R. Int J Cardiol; 2005 May 11; 101(1):77-82. PubMed ID: 15860387 [Abstract] [Full Text] [Related]
12. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism. Wahl A, Jüni P, Mono ML, Kalesan B, Praz F, Geister L, Räber L, Nedeltchev K, Mattle HP, Windecker S, Meier B. Circulation; 2012 Feb 14; 125(6):803-12. PubMed ID: 22238228 [Abstract] [Full Text] [Related]
13. Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events. Petty GW, Khandheria BK, Meissner I, Whisnant JP, Rocca WA, Christianson TJ, Sicks JD, O'Fallon WM, McClelland RL, Wiebers DO. Mayo Clin Proc; 2006 May 14; 81(5):602-8. PubMed ID: 16706256 [Abstract] [Full Text] [Related]
14. Age is not a predictor of patent foramen ovale with right-to-left shunt in patients with cerebral ischemic events. Yahia AM, Shaukat A, Kirmani JF, Qureshi AI. Echocardiography; 2004 Aug 14; 21(6):517-22. PubMed ID: 15298687 [Abstract] [Full Text] [Related]
18. D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale. Kim YD, Song D, Nam HS, Lee K, Yoo J, Hong GR, Lee HS, Nam CM, Heo JH. Thromb Haemost; 2015 Aug 31; 114(3):614-22. PubMed ID: 25994249 [Abstract] [Full Text] [Related]